222 related articles for article (PubMed ID: 29562465)
1. [Impact on platelet recovery of recombinant human thrombopoietin in severe aplastic anemia patients with allogeneic hematopoietic stem cell transplantation].
Song Y; Zhou F; Song NX; Liu XM; Yu Z; Xie LN; Song XC; Li X
Zhonghua Xue Ye Xue Za Zhi; 2018 Mar; 39(3):207-211. PubMed ID: 29562465
[No Abstract] [Full Text] [Related]
2. [Effect of Recombinant Human Thrombopoietin on Platelet Reconstitution after Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma].
Xie Y; Yan LZ; You T; Shi XL; Yan S; Zhai YY; Shang JJ; Yan Z; You HY; Wang QQ; Wu DP; Fu CC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):505-511. PubMed ID: 38660859
[TBL] [Abstract][Full Text] [Related]
3. Recombinant Human Thrombopoietin Promotes Platelet Engraftment in Severe Aplastic Anemia Patients Following Treatment With Haploid Hematopoietic Stem Cell Transplantation using Modified Post-Transplantation Cyclophosphamide.
Fu A; Peng Y; Cheng P; Wu J; Zhu X; Yang Y; Huang L; Wang N; Wang J; Xu J; Wan Y; Cao Y; Wei J; Xiao Y; Meng F; Cheng H; Zhang Y; Zhang D
Transplant Cell Ther; 2024 May; 30(5):500-509. PubMed ID: 38447750
[TBL] [Abstract][Full Text] [Related]
4. [Effect of rhTPO and rhIL-11 on Thrombocytopenia after Chemotherapy in Leukemia].
Dai JF; Xia RX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):711-717. PubMed ID: 35680794
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of Recombinant Human Thrombopoietin and Recombinant Human Interleukin 11 for Treatment of Chemotherapy Indu-ced Thrombocytopenia in Acute Myeloid Leukaemia Patients].
Tang G; Wang XM; Meng JX; Luan CL; Chen JF; Wu YQ; Zhang XN; He ZY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):234-238. PubMed ID: 29397850
[TBL] [Abstract][Full Text] [Related]
6. Recombinant Human Thrombopoietin Promotes Platelet Engraftment and Improves Prognosis of Patients with Myelodysplastic Syndromes and Aplastic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation.
Wang H; Huang M; Zhao Y; Qi JQ; Chen C; Tang YQ; Qiu HY; Fu CC; Tang XW; Wu DP; Ruan CG; Han Y
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1678-1684. PubMed ID: 28642072
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human thrombopoietin treatment promotes hematopoiesis recovery in patients with severe aplastic anemia receiving immunosuppressive therapy.
Wang H; Dong Q; Fu R; Qu W; Ruan E; Wang G; Liu H; Wu Y; Song J; Xing L; Guan J; Li L; Shao Z
Biomed Res Int; 2015; 2015():597293. PubMed ID: 25861635
[TBL] [Abstract][Full Text] [Related]
8. [Impact of recombinant human thrombopoietin (rhTPO) on short-term response of immunosuppressive therapy in patients with newly diagnosed acquired severe aplastic anemia].
Zhang L; Yang W; Ye L; Zhou K; Jing L; Li Y; Li Y; Li J; Peng G; Song L; Zhao X; Wu Z; Zhang F
Zhonghua Xue Ye Xue Za Zhi; 2015 Mar; 36(3):181-5. PubMed ID: 25854458
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the efficacy of cyclosporin A combined with recombined human thrombopoietin for treating patients with non-severe aplastic anemia].
Zhang ML; Chen WS; Han B
Zhonghua Xue Ye Xue Za Zhi; 2020 Aug; 41(8):637-642. PubMed ID: 32942816
[No Abstract] [Full Text] [Related]
10. Effect of c-mpl ligands after total body irradiation (TBI) with and without allogeneic hematopoietic stem cell transplantation: low-dose TBI does not prevent sensitization.
Nash RA; Takatu A; Feng Z; Slichter S; Abrams K; Espino G; Gass MJ; Georges GE; McSweeney PA; Shulman HM; Storb R
Biol Blood Marrow Transplant; 2002; 8(7):360-7. PubMed ID: 12171482
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of efficacy and safety of two different dose of recombinant human thrombopoietin regimens in severe aplastic anemia patients with immunosuppressive therapy].
Zhou K; Li Y; Li JP; Fan HH; Zhang L; Jing LP; Peng GX; Ye L; Li Y; Song L; Zhao X; Yang WR; Wu ZJ; Chen F; Zhang FK
Zhonghua Xue Ye Xue Za Zhi; 2016 Mar; 37(3):205-9. PubMed ID: 27033757
[TBL] [Abstract][Full Text] [Related]
12. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
[TBL] [Abstract][Full Text] [Related]
13. Sequential treatment with rmIL-3 or simultaneous treatment with rmIL-3 or rhIL-11 with thrombopoietin (TPO) fails to enhance in vivo neonatal rat thrombocytopoiesis.
van de Ven C; Fernandez GW; Herbst T; Knoppel A; Cairo MS
Exp Hematol; 1997 Aug; 25(9):1005-12. PubMed ID: 9257814
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human thrombopoietin promotes platelet engraftment after haploidentical hematopoietic stem cell transplantation: a prospective randomized controlled trial.
Han TT; Xu LP; Liu DH; Liu KY; Wang FR; Wang Y; Yan CH; Chen YH; Sun YQ; Ji Y; Wang JZ; Zhang XH; Huang XJ
Ann Hematol; 2015 Jan; 94(1):117-28. PubMed ID: 25069650
[TBL] [Abstract][Full Text] [Related]
15. A novel recombinant human thrombopoietin for treating prolonged isolated thrombocytopenia after allogeneic stem cell transplantation.
Sun YQ; Kong Y; Zhang XH; Wang Y; Shi MM; Song Y; Kong J; Fu HX; Yan CH; Xu LP; Liu KY; Huang XJ
Platelets; 2019; 30(8):994-1000. PubMed ID: 30569802
[TBL] [Abstract][Full Text] [Related]
16. Oral eltrombopag versus subcutaneous recombinant human thrombopoietin for promoting platelet engraftment after allogeneic stem cell transplantation: A prospective, non-inferiority, randomized controlled trial.
Wen B; Zhang X; Chen S; Fan J; Yang S; Cai Y; Wang P; Zhang Q; Gu Q; Du X
Hematol Oncol; 2022 Oct; 40(4):777-786. PubMed ID: 35554955
[TBL] [Abstract][Full Text] [Related]
17. A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation.
Nash RA; Kurzrock R; DiPersio J; Vose J; Linker C; Maharaj D; Nademanee AP; Negrin R; Nimer S; Shulman H; Ashby M; Jones D; Appelbaum FR; Champlin R
Biol Blood Marrow Transplant; 2000; 6(1):25-34. PubMed ID: 10707996
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Recombinant Human Thrombopoietin for the Treatment of Secondary Failure of Platelet Recovery After Allogeneic HSCT.
Cao Y; Wang M; Shen B; Zhao F; Zhang R; Chen X; He Y; Zhai W; Ma Q; Wei J; Huang Y; Yang D; Pang A; Feng S; Jiang E; Han M
Clin Appl Thromb Hemost; 2022; 28():10760296211068037. PubMed ID: 35019756
[TBL] [Abstract][Full Text] [Related]
19. [Effect of recombinant human thrombopoietin on endotoxin-induced thrombocytopenia in mice].
Jiang J; Wang B; Yu X; Xu H; Wang Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Sep; 31(9):1108-1112. PubMed ID: 31657334
[TBL] [Abstract][Full Text] [Related]
20. A real-world observation on thrombopoietic agents for patients with cancer treatment-induced thrombocytopenia in China: A multicenter, cross-sectional study.
Chen M; Li L; Xia Q; Chen X; Liao Z; Wang C; Shen B; Zhou M; Zhang Q; Zhang Y; Qian L; Yuan X; Wang Z; Xue C; An X; Liu B; Gu K; Hou M; Wang X; Wang W; Li E; Zhong J; Cheng J; Shu Y; Yang N; Wang H; Yang R; Liu T; Deng T; Ma F; Liao W; Qiu W; Chen Y; Chen X; Zhang M; Xu R; Li X; Feng J; Ba Y; Shi Y
Cancer; 2024 Apr; 130(S8):1524-1538. PubMed ID: 38515388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
